Clorox up after first-quarter sales, profit beat

** Shares of Pine-Sol maker Clorox CLX.N up 4.4% at $93.72 in extended trading

** Co beats quarterly sales, profit estimates, helped by resilient demand for its health and wellness products

** Reports Q1 sales of $1.91 billion vs estimates of $1.88 billion - data compiled by LSEG

** Logs quarterly adjusted EPS of $1.55, increased 82% vs estimates of $1.07

** Posts 62% rise in net sales of health and wellness segment for the quarter vs 19% decrease last year

** CLX however maintains FY2027 sales forecast and sees annual adjusted EPS results closer to the low end of the range

** "The cost environment has become more challenging, with higher inflationary pressures reflected in our updated outlook" - co

** As of last close, stock down ~11% YTD